Medicines Optimisation

QIPP Initiatives

Commissioning for Quality

MMS® can provide tailored medicines optimisation programmes that support clinicians to provide improved healthcare for their patients. We can work alongside you to provide improved patient outcomes as well as offer significant savings for you and the NHS.

We can implement a fully trained clinical pharmacist to work with patients face to face or manage your medicines optimisation remotely. Our pharmacist can highlight changes that may need to be made with the patient’s therapy and work to provide a solution that is clinically appropriate as well as cost effective.

A MMS® Practice Pharmacist can offer significant savings; with an average of £500,000 saved per year per population of 100,000.
MMS® Practice Pharmacists have been proven to alleviate the GP workload by undertaking medicines related responsibilities. Our pharmacists supported patients to improve compliance and reduce medicines wastage as well as medicines associated harm. Qualitative outcomes were also coupled with a significant reduction in prescribing spend.

QIPP Initiatives

MMS® can provide a series of Therapy Optimisation Programmes that can maximise QIPP potential. These programmes are designed to optimise patient care whist releasing budgetary savings in line with national QIPP challenges.

Our range of therapy optimisation programmes can be offered with flexible models in both delivery and funding. These include part or full sponsorship, in which case clinical reviews may be implemented with no cost implications to your GP Practice, CCG or GP Federation.

An ‘invest to save’ model including options for risk share would typically deliver in excess of a five-fold return on investment. On average our suite of optimisation programmes generate a deliverable saving projection of £500,000 per 100,000 population.

Our programmes are highly customisable and can be tailored to suit your requirements. Please contact MMS® for further information and to speak to a member of our senior clinical team.

Medicines Optimisation Programmes

MMS® have designed over 20 programmes to support NHS QIPP and medicines optimisation priorities
across a broad range of therapy areas & conditions, including; respiratory, malnutrition, osteoporosis, dermatology, inflammatory bowel disease, diabetes, stroke prevention and other cardiovascular conditions.

Key features & benefits include;

  • Optimise therapeutic management of patients

  • Promote alignment to national & local guidance

  • Maximise opportunities to reduce cost and medicines waste

  • Reduce medicines related adverse effects and admissions


Popular MMS® Programmes 

  • Dermatology

    Optimise emollient usage and review
    Ensure cost effective prescribing of emollients
    Reduce flare up related GP and Hospital appointments

  • Oral Nutritional Supplements

    Ensure appropriate prescribing in accordance with local pathways
    Incorporate care home reviews and ONS/MUST training support
    Maximise prescribing efficiencies in management of malnutrition

  • Oral Contraceptives

    To improve adherence to national UKMEC guidance and local prescribing formulary
    Optimise prescribing efficiencies
    Reduce likelihood or drug related adverse effects

  • Type II Diabetes

    Optimise therapy to achieve optimum glycaemic control in Type II Diabetes
    Review therapy in like with NICE guidance NG28
    Maximise QIPP and QOF outcomes

  • Asthma & COPD

    Review and optimise prescribing in line with updated guidance
    Reduce fluticasone burden and associated risks
    Optimise therapeutic management of Asthma and COPD

  • Care Home Support

    Polypharmacy review - STOPP/START
    Reduce wastage of medicines
    Reduce risk and unnecessary hospital admissions

  • Blood Glucose Testing

    Review and rationalise SMBG in Type II Diabetes
    Facilitate transition to formulary choice test strips
    Appropriate and cost effective prescribing

  • Atrial Fibrillation & Stroke Prevention

    Risk stratify and identify patients at risk of nvAF related stroke
    Optimise therapeutic management to reduce incidence of avoidable strokes
    Review to highlight QIPP opportunities within DOAC prescribing

  • Opioid Pain Relief

    Review prescribing in line with CQC and NHS England recommendations
    Review prescribing in line with the WHO Pain Ladder
    Review palliative care QOF indicators maximising outcomes for patients and the practice

  • Mental Health

    Incorporating Alzheimer's, Parkinson's and Schizophrenia
    Review for appropriate therapeutic monitoring and discharge reconcilliation
    Optimise prescribing efficiencies by prescribing with the lowest acquisition cost

Commissioning for quality

MMS® can provide skilled clinical pharmacists to undertake patient centred clinical review projects to improve patient health outcomes in line with CCG objectives and NHS Right Care strategies.
MMS® have experience in delivering in the following areas:

  • Care Home Reviews
  • Stroke Prevention
  • Domiciliary and Frailty Reviews
  • Reducing risk of hospital admission / Virtual Clinics
  • Embedding GP Practice Pharmacists

Please contact MMS for more information on our Medicines Optimisation Programmes or to speak to one of our Senior Clinical Team

Contact Us